CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 135 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $384,000 | -4.0% | 88,102 | 0.0% | 0.01% | -14.3% |
Q1 2021 | $400,000 | -20.9% | 88,102 | 0.0% | 0.01% | -22.2% |
Q4 2020 | $506,000 | -20.7% | 88,102 | 0.0% | 0.02% | -25.0% |
Q3 2020 | $638,000 | +107.8% | 88,102 | 0.0% | 0.02% | +100.0% |
Q2 2020 | $307,000 | +136.2% | 88,102 | 0.0% | 0.01% | +100.0% |
Q1 2020 | $130,000 | -24.9% | 88,102 | 0.0% | 0.01% | -14.3% |
Q4 2019 | $173,000 | -61.6% | 88,102 | 0.0% | 0.01% | -65.0% |
Q3 2019 | $451,000 | -28.5% | 88,102 | 0.0% | 0.02% | -23.1% |
Q2 2019 | $631,000 | -66.5% | 88,102 | -48.2% | 0.03% | -61.8% |
Q3 2018 | $1,883,000 | -17.4% | 169,962 | 0.0% | 0.07% | -21.8% |
Q2 2018 | $2,281,000 | +3.3% | 169,962 | 0.0% | 0.09% | +1.2% |
Q1 2018 | $2,208,000 | +14.3% | 169,962 | -19.1% | 0.09% | +14.7% |
Q4 2017 | $1,932,000 | +14.2% | 209,962 | 0.0% | 0.08% | +25.0% |
Q3 2017 | $1,692,000 | – | 209,962 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 2,254,502 | $20,741,000 | 14.54% |
Versant Venture Management, LLC | 1,048,601 | $9,647,127,000 | 10.15% |
Abingworth LLP | 1,147,077 | $10,553,000 | 7.65% |
Omega Fund Management, LLC | 551,477 | $5,074,000 | 3.67% |
Opaleye Management Inc. | 665,000 | $6,118,000 | 1.96% |
DAFNA Capital Management LLC | 361,164 | $3,323,000 | 1.79% |
Boxer Capital, LLC | 1,012,986 | $9,319,000 | 1.70% |
Foresite Capital Management III, LLC | 600,000 | $5,520,000 | 1.55% |
NEXTHERA CAPITAL LP | 536,568 | $4,936,000 | 0.91% |
Perceptive Advisors | 2,685,882 | $24,710,000 | 0.82% |